Abstract
Cardiac hypertrophy with maladjusted cardiac remodeling is the leading cause of heart failure. In the past decades, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been proved to exert multiple functions in cellular biological behaviors; however, their role in cardiac hypertrophy remains largely unclear. Presently, we first obtained hypertrophic H9c2 cells by treating with angiotensin II (Ang II) and uncovered upregulation of lncRNA taurine upregulated gene 1 (TUG1) in such H9c2 cells. Then, we demonstrated that silencing TUG1 attenuated Ang II–induced cardiac hypertrophy. Besides, a strong interactivity of TUG1 with miR-29b-3p at the putative sites was validated, suggesting that TUG1 was an endogenous sponge of miR-29b-3p in H9c2 cells. Additionally, the expression of miR-29b-3p was strikingly reduced by TUG1 upregulation and also inhibited under Ang II treatment, whereas it was restored after silencing TUG1 in hypertrophic cells. Also, we proved miR-29b-3p as a negative regulator in cardiac hypertrophy. Finally, miR-29b-3p inhibition abolished the anti-hypertrophy effect of TUG1 depletion in Ang II–treated H9c2 cells. Collectively, our findings confirmed that TUG1 functioned as a positive modulator of cardiac hypertrophy via sponging miR-29b-3p, indicating that TUG1 might serve as a potential target for the treatment of cardiac hypertrophy and even heart failure.
Similar content being viewed by others
References
Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191–227
Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, Li Z, Shang X, Liu Y (2015) The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget 6:19759–19779
Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613–618
Chen L (2017) MiR-29b-3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN, vol 21, pp 3347–3359
Diwan A, Dorn GW 2nd (2007) Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 22:56–64
Drummond C, Hill M, Shi H, Fan X, Xie J, Haller S, Kennedy D, Liu J, Garrett M, Xie Z, Cooper C, Shapiro J, Tian J (2016) Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts. Physiol Genomics 48:220–229
Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79
Han D, Gao Q, Cao F (2017) Long noncoding RNAs (LncRNAs) - the dawning of a new treatment for cardiac hypertrophy and heart failure. Biochim Biophys Acta 1863:2078–2084
Jiang N, Xia J, Jiang B, Xu Y, Li Y (2018) TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells. Biomed Pharmacother 103:1669–1677
Jiang W, Zhang Z, Yang H, Lin Q, Han C, Qin X (2017) The involvement of miR-29b-3p in arterial calcification by targeting matrix metalloproteinase-2. Biomed Res Int 2017
Kakimoto Y, Tanaka M, Hayashi H, Yokoyama K, Osawa M (2018) Overexpression of miR-221 in sudden death with cardiac hypertrophy patients. Heliyon 4:e00639
Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D (2013) Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc 2:e000078
Karapetyan AR, Buiting C, Kuiper RA, Coolen MW (2013) Regulatory roles for long ncRNA and mRNA. Cancers (Basel) 5:462–490
Klinge CM (2018) Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. Endocr Relat Cancer 25:R259–R282
Leistner DM, Boeckel J-N, Reis SM, Thome CE, De Rosa R, Keller T, Palapies L, Fichtlscherer S, Dimmeler S, Zeiher AM (2016) Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. Eur Heart J 37:1738–1749
Li C, Zhou G, Feng J, Zhang J, Hou L, Cheng Z (2018) Upregulation of lncRNA VDR/CASC15 induced by facilitates cardiac hypertrophy through modulating miR-432-5p/TLR4 axis. Biochem Biophys Res Commun 503:2407–2414. https://doi.org/10.1016/j.bbrc.2018.06.169
Liu L, An X, Li Z, Song Y, Li L, Zuo S, Liu N, Yang G, Wang H, Cheng X, Zhang Y, Yang X, Wang J (2016) The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc Res 111:56–65
Liu Q, Liu H, Cheng H, Li Y, Li X, Zhu C (2017) Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells. Onco Targets Ther 10:2461–2471
Long J, Menggen Q, Wuren Q, Shi Q, Pi X (2018) Long noncoding RNA taurine-upregulated gene1 (TUG1) promotes tumor growth and metastasis through TUG1/Mir-129-5p/astrocyte-elevated gene-1 (AEG-1) axis in malignant melanoma. Med Sci Monit 24:1547–1559
Lv L, Li T, Li X, Xu C, Liu Q, Jiang H, Li Y, Liu Y, Yan H, Huang Q, Zhou Y, Zhang M, Shan H, Liang H (2018) The lncRNA Plscr4 controls cardiac hypertrophy by regulating miR-214. Mol Ther Nucleic Acids 10:387–397
Marques F, Vizi D, Khammy O, Mariani J, Kaye D (2016) The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail 18:1000–1008
Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159
Rainer J, Meraviglia V, Blankenburg H, Piubelli C, Pramstaller PP, Paolin A, Cogliati E, Pompilio G, Sommariva E, Domingues FS, Rossini A (2018) The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells. BMC Genomics 19:491
Schirone L, Forte M, Palmerio S, Yee D, Nocella C, Angelini F, Pagano F, Schiavon S, Bordin A, Carrizzo A, Vecchione C, Valenti V, Chimenti I, De Falco E, Sciarretta S, Frati G (2017) A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxidative Med Cell Longev 2017:3920195
Shao M, Chen G, Lv F, Liu Y, Tian H, Tao R, Jiang R, Zhang W, Zhuo C (2017) LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII. Oncotarget 8:47565–47573
Shen S, Jiang H, Bei Y, Xiao J, Li X (2017) Long non-coding RNAs in cardiac remodeling. Cell Physiol Biochem 41:1830–1837
Tang D, Zhao D, Wu Y, Yao R, Zhou L, Lu L, Gao W, Sun Y (2018) The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer. J Cell Mol Med 22:3847–3856. https://doi.org/10.1111/jcmm.13657
Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344–352
Thum T, Condorelli G (2015) Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res 116:751–762
Tu J, Zhao Z, Xu M, Lu X, Chang L, Ji J (2018) NEAT1 upregulates TGF-beta1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p. J Cell Physiol 233:8578–8587. https://doi.org/10.1002/jcp.26524
Wang Q, Chen Q (2018) Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma. J Cancer Res Ther 14:405–409
Wang RY, Rudser KD, Dengel DR, Braunlin EA, Steinberger J, Jacobs DR, Sinaiko AR, Kelly AS (2017) The carotid intima-media thickness and arterial stiffness of pediatric Mucopolysaccharidosis patients are increased compared to both pediatric and adult controls. Int J Mol Sci 18
Widlansky ME (2018) miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders. 10
Xu Y, Deng W, Zhang W (2018) Long non-coding RNA TUG1 protects renal tubular epithelial cells against injury induced by lipopolysaccharide via regulating microRNA-223. Biomed Pharmacother 104:509–519
Yang B, Tang X, Wang Z, Sun D, Wei X, Ding Y (2018) TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a. Biosci Rep 38:BSR20180677. https://doi.org/10.1042/bsr20180677
Yang T, Gu H, Chen X, Fu S, Wang C, Xu H, Feng Q, Ni Y (2014) Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo. J Surg Res 192:317–325
Zhu X, Yuan Y, Rao S, Wang P (2016) LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. Eur Rev Med Pharmacol Sci 20:3653–3660
Zhu Y, Feng Z, Jian Z, Xiao Y (2018a) Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR-29c in chronic hypoxia. Mol Med Rep 18:3451–3460
Zhu YFZ, Jian Z, Xiao Y (2018b) Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR-29c in chronic hypoxia. Mol Med Rep 35:29–36
Acknowledgements
Thank you for all the participators.
Funding
This work was funded by the role of GRK4 methylation in the hypertension induced by pregnancy cold-exposure.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Zou, X., Wang, J., Tang, L. et al. LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p. In Vitro Cell.Dev.Biol.-Animal 55, 482–490 (2019). https://doi.org/10.1007/s11626-019-00368-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-019-00368-x